Richmond, CA, United States of America

Weiya Yun


Average Co-Inventor Count = 5.0

ph-index = 2

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 2000-2001

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Weiya Yun: Innovator in Anti-Coagulant Research

Introduction

Weiya Yun is a notable inventor based in Richmond, CA (US), recognized for his contributions to the field of pharmaceuticals. He holds a total of 3 patents that focus on innovative compounds with significant medical applications.

Latest Patents

One of his latest patents is titled "Benzamidine derivatives substituted by amino acid and hydroxy acid derivatives and their use as anti-coagulants." This invention is directed to benzamidine derivatives that are substituted by amino acid and hydroxy acid derivatives, which are useful as anti-coagulants. The invention also encompasses pharmaceutical compositions containing these compounds and methods for using them to treat disease-states characterized by thrombotic activity. Another patent, "Benzamidine derivatives substituted by amino acid and hydroxy acid," shares similar objectives and applications, further emphasizing the importance of these compounds in medical treatments.

Career Highlights

Weiya Yun is currently associated with Berlex Laboratories, Inc., where he continues to advance his research and development efforts. His work has significantly contributed to the understanding and treatment of thrombotic conditions, showcasing his commitment to improving patient outcomes through innovative solutions.

Collaborations

Throughout his career, Weiya has collaborated with notable colleagues, including Monica J Kochanny and Raju Mohan. These partnerships have fostered a collaborative environment that enhances the research and development process.

Conclusion

Weiya Yun's innovative work in the field of anti-coagulants demonstrates his dedication to advancing medical science. His patents reflect a commitment to addressing critical health issues, making him a valuable contributor to the pharmaceutical industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…